Cadazolid
Cadazolid (pronounced: ka-daz-o-lid) is a novel antibiotic developed for the treatment of Clostridium difficile infection (CDI). It is a oxazolidinone-fluoroquinolone hybrid antibiotic, which means it combines the mechanisms of action of these two classes of antibiotics.
Etymology
The name "Cadazolid" is derived from the combination of the words "Cada" and "Zolid", which represent the two classes of antibiotics it is derived from: oxazolidinone and fluoroquinolone.
Mechanism of Action
Cadazolid works by inhibiting the synthesis of proteins and DNA in the bacterial cell, thereby stopping the growth and reproduction of the bacteria. It is particularly effective against Clostridium difficile, a bacterium that can cause severe diarrhea and life-threatening inflammation of the colon.
Related Terms
See Also
External links
- Medical encyclopedia article on Cadazolid
- Wikipedia's article - Cadazolid
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski